Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

BACKGROUND: Immunotherapy is effective in treating unresectable esophageal squamous cell carcinoma (ESCC), but little is known about its role in the preoperative setting. The aim of this study was to evaluate the safety, feasibility and efficacy of neoadjuvant treatment with camrelizumab plus chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guozhen, Su, Xiaodong, Yang, Hong, Luo, Guangyu, Gao, Chan, Zheng, Yating, Xie, Wenzhuan, Huang, Mengli, Bei, Ting, Bai, Yuezong, Wang, Zhiqiang, Cai, Peiqiang, He, Haoqiang, Xiang, Jin, Cai, Muyan, Zhang, Yijun, Qu, Chunhua, Fu, Jianhua, Liu, Qianwen, Hu, Yi, Zhong, Jiudi, Huang, Yuanheng, Guo, Qiyu, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421958/
https://www.ncbi.nlm.nih.gov/pubmed/34532391
http://dx.doi.org/10.21037/atm-21-3352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421958/
https://www.ncbi.nlm.nih.gov/pubmed/34532391
http://dx.doi.org/10.21037/atm-21-3352

Ejemplares similares